Resistance to targeted therapies in breast cancer

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast can...

Full description

Saved in:
Bibliographic Details
Other Authors Prosperi, Jenifer R. (Editor)
Format Electronic eBook
LanguageEnglish
Published Cham, Switzerland : Springer, [2017]
SeriesResistance to targeted anti-cancer therapeutics ; v. 16.
Subjects
Breast > Cancer > Chemotherapy.
Drug resistance in cancer cells.
elektronické knihy
electronic books
Online AccessFull text
ISBN9783319701424
9783319701417
ISSN2196-551X ;
Physical Description1 online resource

Cover

Table of Contents:
  • Invasive Breast Cancer Therapy 2017: How Well Are We Hitting The Target?
  • Resistance to HER2-targeted therapy
  • Endocrine Resistance and Breast Cancer Stem Cells? The Inflammatory Connection That Could Lead to New and Improved Therapy Outcomes
  • EGFR Resistance
  • Targeting FGFR for the treatment of breast cancer
  • Targeted Therapies in Breast Cancer
  • Future paradigm of breast cancer resistance and treatment.

Similar Items